Myval Octacor and Octapro Trans-Catheter Heart Valves in Patients with Severe Pure Non Calcified Native Aortic Regurgitation
Alfonso Ielasi, Rodolfo Caminiti, Mariano Pellicano, Andrea Marrone, Dario Pellegrini, Carlo Banfi, Mattia Glauber, Maurizio Tespili · 2026
Read Myval Octacor and Octapro Trans-Catheter Heart Valves in Patients with Severe Pure Non Calcified Native Aortic Regurgitation by Alfonso Ielasi, Rodolfo Caminiti, Mariano Pellicano, Andrea Marrone, Dario Pellegrini, Carlo Banfi, Mattia Glauber, Maurizio Tespili (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13099935.txt.
Description
Backgroundthe treatment of high-risk or inoperable patients with severe, pure native non calcified aortic regurgitation (NCAR) poses unique procedural challenges for the trans-catheter technologies. In particular the lack of leaflet calcification and dilated aortic anatomies increase the risk of technical failure with the currently available trans-catheter heart valves (THV).
Catalog record
| CREATOR | Alfonso Ielasi, Rodolfo Caminiti, Mariano Pellicano, Andrea Marrone, Dario Pellegrini, Carlo Banfi, Mattia Glauber, Maurizio Tespili |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |